{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:15:23Z","timestamp":1793146523816,"version":"4.5.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Treating autoimmune diseases without nonspecific immunosuppression remains challenging. To prevent or treat these conditions through targeted immunotherapy, we developed a clinical-stage nanoparticle platform that leverages the tolerogenic capacity of liver sinusoidal endothelial cells (LSECs) to restore antigen-specific immune tolerance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vivo<\/jats:italic>\n                      efficacy was evaluated in various CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell-mediated disease models, including preventive and therapeutic models of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE), ovalbumin-sensitized delayed-type hypersensitivity (DTH), and the spontaneous type 1 diabetes model. Nanoparticle-induced antigen-specific immune responses were also analyzed through adoptive transfers of 2D2 transgenic T cells into wild-type mice, followed by nanoparticle administration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The peptide-conjugated nanoparticles displayed a uniform size distribution (25\u201330 nm). Their coupling efficiency for peptides with unfavorable physicochemical properties was significantly enhanced by a proprietary linker technology. Preferential LSEC targeting of nanoparticles coupled with fluorescently labeled peptides was confirmed via intravital microscopy and flow cytometry. Intravenous nanoparticle administration significantly reduced disease severity and demyelination in EAE, independent of prednisone at maintenance doses, and suppressed target tissue inflammation in the DTH model. Furthermore, prophylactic administration of a mixture of nanoparticles coupled with five autoantigenic peptides significantly lowered the hyperglycemia incidence of the non-obese diabetic mice. Mechanistically, the tolerizing effects were associated with the induction of antigen-specific regulatory T cells and T cell anergy, which counteract proinflammatory T cells in the target tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that peptide-loaded nanoparticles preferentially deliver disease-relevant peptides to LSECs, thereby inducing antigen-specific immune tolerance. This versatile clinical-stage nanoparticle platform holds promise for clinical application across multiple autoimmune diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1542380","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T03:22:16Z","timestamp":1742181736000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models"],"prefix":"10.3389","volume":"16","author":[{"given":"Shu-Hung","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Serr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo","family":"Digigow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Surnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Gottwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Alsamman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Krzikalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Zahlten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Widera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Mungalpara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharrem","family":"S\u0327eleci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fanzutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edgia Margarida","family":"Marques Mesquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lisa","family":"Vocaturo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Herkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Carambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schr\u00f6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikran","family":"Sarko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Pohlner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"de Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.99107s5661","article-title":"Introduction to immunology and autoimmunity","volume":"107","author":"Smith","year":"1999","journal-title":"Environ Health Perspect"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar1703","article-title":"The role of the T cell in autoimmune inflammation","volume":"7","author":"Skapenko","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.2011.01019.x","article-title":"Mechanisms of tolerance","volume":"241","author":"Bluestone","year":"2011","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00674","article-title":"Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies","volume":"11","author":"Cauwels","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/annrheumdis-2018-214024","article-title":"Tolerising cellular therapies: what is their promise for autoimmune disease","volume":"78","author":"Mosanya","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"115194","DOI":"10.1016\/j.addr.2024.115194","article-title":"Emerging strategies for nanomedicine in autoimmunity","volume":"207","author":"Thatte","year":"2024","journal-title":"Adv Drug Delivery Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41467-021-27945-7","article-title":"Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia","volume":"13","author":"Sands","year":"2022","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0424-1","article-title":"Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes","volume":"3","author":"Wilson","year":"2019","journal-title":"Nat BioMed Eng"},{"key":"B10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: A randomized, double-blind, placebo-controlled study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00107-3","article-title":"Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial","volume":"8","author":"Murray","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00942-8","article-title":"Harnessing the liver to induce antigen-specific immune tolerance","volume":"44","author":"Gottwick","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.01.006","article-title":"Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice","volume":"62","author":"Carambia","year":"2015","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/imm.v162.4","article-title":"Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis","volume":"162","author":"Carambia","year":"2021","journal-title":"Immunology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444470","article-title":"Endosomal compartment: Also a dock for MHC class I peptide loading","volume":"44","author":"Ma","year":"2014","journal-title":"Eur J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2015.08.019","article-title":"The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes","volume":"66","author":"Pearson","year":"2016","journal-title":"J Autoimmun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"Nakayama","year":"2005","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200208","article-title":"Tolerogenic immune-modifying nanoparticles encapsulating multiple recombinant pancreatic \u03b2 Cell proteins prevent onset and progression of type 1 diabetes in nonobese diabetic mice","volume":"209","author":"Podojil","year":"2022","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis","volume":"66","author":"Masamune","year":"2017","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/08916930802011258","article-title":"Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis","volume":"41","author":"Chan","year":"2008","journal-title":"Autoimmunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-017-0978-3","article-title":"Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties","volume":"14","author":"Prajeeth","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2027","article-title":"ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444687","article-title":"Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells","volume":"44","author":"Reynolds","year":"2014","journal-title":"Eur J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"108748","DOI":"10.1016\/j.celrep.2021.108748","article-title":"Dynamic adoption of anergy by antigen-exhausted CD4+ T cells","volume":"34","author":"Trefzer","year":"2021","journal-title":"Cell Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3331","article-title":"CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors","volume":"17","author":"Kalekar","year":"2016","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nano.2016.09.007","article-title":"An antigen-encapsulating nanoparticle platform for TH1\/17 immune tolerance therapy","volume":"13","author":"McCarthy","year":"2017","journal-title":"Nanomedicine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"121457","DOI":"10.1016\/j.biomaterials.2022.121457","article-title":"Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance","volume":"283","author":"Casey","year":"2022","journal-title":"Biomaterials"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637469","article-title":"Enhancement of the tolerogenic phenotype in the liver by immTOR nanoparticles","volume":"12","author":"Ilyinskii","year":"2021","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.757469","article-title":"The scavenger function of liver sinusoidal endothelial cells in health and disease","volume":"12","author":"Bhandari","year":"2021","journal-title":"Front Physiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.027","article-title":"TGF-\u03b2-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells","volume":"61","author":"Carambia","year":"2014","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.5","article-title":"Immunological functions of liver sinusoidal endothelial cells","volume":"13","author":"Knolle","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21457","article-title":"Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion","volume":"45","author":"Kingham","year":"2007","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7403796","article-title":"Regulation of inflammation in autoimmune disease","volume":"2019","author":"Duan","year":"2019","journal-title":"J Immunol Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.08.057","article-title":"Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity","volume":"138","author":"Kern","year":"2010","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.60","article-title":"The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer","volume":"15","author":"Wisse","year":"2008","journal-title":"Gene Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707302","article-title":"Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo","volume":"151","author":"Ramos","year":"2007","journal-title":"Br J Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972108","article-title":"Comparative effects of human-equivalent low, moderate, and high dose oral prednisone intake on autoimmunity and glucocorticoid-related toxicity in a murine model of environmental-triggered lupus","volume":"13","author":"Heine","year":"2022","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.08.005","article-title":"Induction of T cell anergy: integration of environmental cues and infectious tolerance","volume":"22","author":"Chappert","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00713.x","article-title":"IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules","volume":"114","author":"Knolle","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/cells10061530","article-title":"Strength and numbers: the role of affinity and avidity in the \u2018Quality\u2019 of T cell tolerance","volume":"10","author":"This","year":"2021","journal-title":"Cells"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1782","article-title":"A miRNA181a\/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes","volume":"10","author":"Serr","year":"2018","journal-title":"Sci Transl Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"10991","DOI":"10.1038\/ncomms10991","article-title":"Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice","volume":"7","author":"Serr","year":"2016","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.2015.2928","article-title":"Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes","volume":"313","author":"Bonifacio","year":"2015","journal-title":"JAMA"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3762\/bjnano.5.155","article-title":"The cell-type specific uptake of polymer-coated or micelle-embedded QDs and SPIOs does not provoke an acute pro-inflammatory response in the liver","author":"Heine","year":"2014","journal-title":"Beilstein J Nanotechnology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2297","article-title":"Brown adipose tissue activity controls triglyceride clearance","volume":"17","author":"Bartelt","year":"2011","journal-title":"Nat Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-481-4","article-title":"Delayed-type hypersensitivity models in mice","volume":"1031","author":"Allen","year":"2013","journal-title":"Methods Mol Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250723","article-title":"A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2 b mice: Fine specificity and T cell receptor V\u03b2 expression of encephalitogenic T cells","volume":"25","author":"Mendel","year":"1995","journal-title":"Eur J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.steroids.2016.10.008","article-title":"Continuous corticosterone delivery via the drinking water or pellet implantation: A comparative study in mice","volume":"116","author":"Gasparini","year":"2016","journal-title":"Steroids"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250430","article-title":"Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice","volume":"25","author":"Daniel","year":"1995","journal-title":"Eur J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.9.4926","article-title":"Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes","volume":"167","author":"Chen","year":"2001","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0932778100","article-title":"Identification of the \u03b2 cell antigen targeted by a prevalent population of pathogenic CD8 + T cells in autoimmune diabetes","volume":"100","author":"Lieberman","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Sci (1979)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2013.10.003","article-title":"Chromogranin A is a T cell antigen in human type 1 diabetes","volume":"50","author":"Gottlieb","year":"2014","journal-title":"J Autoimmun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1844","article-title":"Chromogranin A is an autoantigen in type 1 diabetes","volume":"11","author":"Stadinski","year":"2010","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192135","article-title":"Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation","volume":"218","author":"Reed","year":"2021","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1542380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T03:22:21Z","timestamp":1742181741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1542380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2025.1542380"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1542380","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"article-number":"1542380"}}